期刊文献+

En-block切除术联合结构性植骨治疗第1跖趾关节痛风性关节炎 被引量:9

Treatment of first metatarsophalangeal jointTreatment joint gouty arthritis by arthrodesis withgouty with En-block resection and structural bone graftEn-block graft
下载PDF
导出
摘要 背景:痛风性关节炎最常累及第1跖趾关节关节,伴有肿痛、畸形及关节僵硬,严重影响患者的生活质量。目的:探讨采用En-block切除术结合结构性植骨关节融合治疗第1跖趾关节痛风性关节炎的手术技术及疗效。方法:2012年6月至2013年6月,我院共收治8例第1跖趾关节痛风性关节炎患者。男7例,女1例,年龄25~68岁,平均47.6岁。所有患者均采用En-block病灶切除结合结构性植骨第1跖趾关节融合术。术后定期复查,摄片明确愈合情况,并采用美国骨科足踝外科协会(AOFAS)前足评分及疼痛直观模拟量表(VAS)评价治疗效果,记录相关并发症。结果:所有患者伤口均一期愈合,未见伤口感染、皮肤坏死等软组织并发症。术后7例患者获得12~24个月随访,平均18个月。影像学检查明确术后平均10周融合端骨性愈合。AOFAS评分从术前平均(44.4±10.5)分提高至术后(80.0±10.8)分,而VAS评分从术前平均(7.0±2.0)分降至术后(1.1±0.9)分,其差异均有统计学意义(P<0.0001)。随访期间未见骨不连、畸形愈合及固定失效等并发症。结论:En-block切除结合结构性植骨融合治疗第1跖趾关节痛风性关节炎具有症状缓解明显、融合率高、并发症少等优势,可有效改善患者生活质量,是一种安全有效的治疗方式。 Background:Gouty arthritis most commonly involves the first metatarsophalangeal joint (MTPJ), causing pain, deformity and anchylosis and reducing patients' quality of life. Objective:To investigate the technique and clinical outcome of arthrodesis with En-block resection and structural bone graft to treat the 1st MTPJ gouty arthritis. Methods: From June 2012 to June 2013, 8 patients suffering from 1st MTPJ gouty arthritis were treated in our hospital. There were 7 men and 1 woman with an average age of 47.6 years (range 25-68 years). The first MTPJ arthrodesis with En-block resection and structural bone graft was performed in all patients. X-rays were taken in regular follow-up to confirm the fusion union. Overall functional evaluation was carried out according to visual analogue scale (VAS) and the forefoot score of American Orthopaedic Foot and Ankle Society (AOFAS) at the last follow-up. Complications were also recorded. Results:All wounds were healed without any soft tissue complications of infection or skin necrosis. Seven patients got the final follow-up of an average 18 months (range, 12-24 months). X-ray demonstrated the bone union of fusion 10 weeks post-operatively on average. AOFAS score was improved from 44.4 ± 10.5 preoperatively to 80.0 ± 10.8 postoperatively, while VAS score was decreased from 7.0±2.0 to 1.1±0.9. There were significant differences in AOFAS and VAS scores before and after surgery (P〈0.0001). No complications, such as non-union, malunion or implant failure occurred during follow-up. Conclusions:Arthrodesis with En-block resection and structural bone graft can effectively relieve pain, achieve high fusion rate and low complication rate and improve patients' quality of life for the treatment of 1st MTPJ gouty arthritis. It is an effec-tive and safe procedure.
出处 《中国骨与关节外科》 2014年第4期271-275,共5页 Chinese Journal of Bone and Joint Surgery
关键词 En-block切除 第1跖趾关节 痛风性关节炎 关节融合术 植骨 En-block resection first metatarsophalangeal joint gouty arthritis arthrodesis bone graft
  • 相关文献

参考文献15

  • 1Roubenoff R, Klag M J, Mead LA, et al. Incidence and risk factors for gout in white men. JAMA, 1991, 266(21): 3004- 3007.
  • 2Kienhorst LB, Janssens H J, Fransen J, et al. Arthritis of thefirst metatarsophalangeal joint is not always gout: A pro- spective cohort study in primary care patients. Joint Bone Spine, 2014, 81(4): 342-346.
  • 3Simkin PA, Campbell PM, Larson EB. Gout in Heberden'snodes. Arthritis Rheum, 1983, 26(1): 94-97.
  • 4Roddy E, Zhang W, Doherty M. Gout and nodal osteoarthri- tis: a case-control study. Rheumatology, 2008, 47: 732-733.
  • 5Zhu Y, Pandya B J, Choi HK. Comorbidities of gout and hy- peruricemia in the US general population: NHANES 2007- 2008. Am J Med, 2012, 125(7): 679-687.
  • 6Lee SS, Lin SD, Lai CS, et al. The soft-tissue shaving proce- dure for deformity management of chronic tophaceous gout. Ann Plast Surg, 2003, 51(4): 372-375.
  • 7Lui TH. Endoscopic resection of the gouty tophi of the first metatarsophalangeal joint. Arch Orthop Trauma Surg, 2008, 128(5): 521-523.
  • 8Wang CC, Lien SB, Huang GS, et al. Arthroscopic elimina- tion of monosodium urate deposition of the first metatarso- phalangeal joint reduces the recurrence of gout. Arthrosco- py, 2009, 25(2): 153-158.
  • 9Lin CT, Chang SC, Chen TM, et al. Free-flap resurfacing of tissue defects in the foot due to large gouty tophi. Microsur- gery, 2011, 31(8): 610-615.
  • 10Taraz-Jamshidi MH, Gharadaghi M, Mazloumi SM, et al.Clinical outcome of en-block resection and reconstruction with nonvascularized fibular autograft for the treatment of giant cell tumor of distal radius. J Res Med Sci, 2014, 19 (2): 117-121.

同被引文献85

  • 1于涛,俞光荣.第一跖趾关节镜在矫治拇外翻中的应用进展[J].外科研究与新技术,2012,1(2):162-164. 被引量:4
  • 2熊剑秋.超前镇痛应用于关节置换患者的围手术期护理[J].护理学报,2006,13(12):35-37. 被引量:6
  • 3宣昭鹏,路来金,刘志刚,张志新.上肢慢性痛风性关节炎的手术治疗[J].中国矫形外科杂志,2007,15(1):68-69. 被引量:6
  • 4闫合德,高伟阳,李志杰,洪建军,陈星隆,李晓阳.手腕部痛风石手术治疗的临床效果[J].中华手外科杂志,2007,23(3):143-145. 被引量:20
  • 5黄泰康,陈德济.中医风湿病学[M].北京:中国医药科技出版社,2003:59.
  • 6SCHUMACHE HR, BECKER M, LLOYD E, et al. Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study[J]. Rheumatology, 2009, 48(2): 188-194.
  • 7BRUCE SP. Febuxostat: a selective xanthine oxidase inhibitor for the treatment of hyperuricemia and gout[J].the Annals of Phar- macotherapy, 2006, 40(12): 2187-2194.
  • 8SCHUMACHER HR, BECKER MA, WORTMANN RL, et al. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase m, randomized, double-blind, parallel-group trial [J]. Arthritis Rheumatism, 2008, 59(11): 1540-1548.
  • 9SULLIVAN JR, SHEAR NH. The drug hypersensitivity syndrome: what is the pathogenesis[J]. Arch Dermatol, 2001, 137(3): 357-364.
  • 10BECKER MA, SCHUMACHER H, ESPINOZA LR, et al. The u- rate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial[J]. Arthritis Re- search Therapy, 2010, 12(2): 36.

引证文献9

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部